Source: The Pharma Letter

ImmBio: Anglo-Sino collaboration on vaccine against pneumococcal disease

UK vaccine R&D company ImmunoBiology (ImmBio) has recently signed a licensing agreement with LIBP (Lanzhou...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



ImmBio is a Private company. ImmBio generates $1M in revenue per employee